AGK-10111

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAGK-10111
Drug Alias Nameselective insulin receptor modulator (TheraKine)AGK-10111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin receptor modulators
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheraKine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheraKine Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A